MERCER GLOBAL ADVISORS INC /ADV - KINIKSA PHARMACEUTICALS LTD ownership

Quarter-by-quarter ownership
MERCER GLOBAL ADVISORS INC /ADV ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$298
-8.9%
17,158
-26.1%
0.00%0.0%
Q2 2023$327
+67.7%
23,224
+27.8%
0.00%0.0%
Q1 2023$19518,1660.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders